Observational studyEndocrine2019
Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group.
Antongiulio Faggiano et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it